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True abdominal aortic aneurysm in Marfan
syndrome
Toshio Takayama, MD, Tetsuro Miyata, MD, and Hirokazu Nagawa, MD, Tokyo, Japan
Objectives:True abdominal aortic aneurysm (AAA) in patients withMarfan syndrome is relatively rare because most aortic
aneurysms in this disease are dissecting aneurysms in the thoracic area. Therefore, its clinical characteristics and long-term
outcome are still unclear.
Methods: We examined six patients (3 men, 3 women) with Marfan syndrome who had a true AAA. These patients
underwent surgical treatment from 1972 to 2004, and we investigated the clinical and histologic findings.
Results: The patients were a median age of 45 years (range, 23-73 years) at the time of operation. The median maximum
AAA diameter was 76 mm (range, 30-140 mm). Two AAAs ruptured, one of which had twice undergone stent graft
insertion before open repair. There was one anastomotic aneurysm and three aortic dissections with additional repair.
Marfan-related cardiac complications, all found perioperatively or postoperatively, comprised three patients with
annuloaortic ectasia and four with aortic regurgitation. Three patients died, including one death during the operation.
Only slight mural thrombus was seen at nonruptured AAAs, and each surgical specimen of aneurysmal wall demonstrated
significant cystic medial necrosis in the tunica media.
Conclusions: True AAAs in Marfan syndrome seemed to have several specific features, such as the tendency to occur in
relatively young patients, lack of mural thrombus, and susceptibility to dissection and rupture, and the patients have poor
life expectancy. Therefore, careful follow-up, keeping these features in mind, is important to treat Marfan syndrome
patients with a true AAA. (J Vasc Surg 2009;49:1162-5.)Marfan syndrome is a congenital disorder of connective
tissue that is associated with various systemic complications
in the skeleton,1 eyes,2 and cardiovascular system.3 It is
inherited as an autosomal dominant condition, and the
defective gene has been mapped to the fibrillin-1 (FBN1)
gene on chromosome 15.4-6 Several resent studies have
revealed that the second fibrillin gene, FBN2, is also con-
cerned in the pathogenesis of this syndrome.4,7 Mutations
of these genes lead to defects in multiple organ systems;
among these systemic complications, those of the cardio-
vascular system are the most critical because most deaths
are due to aortic or mitral valve incompetence, aortic
dissection, aneurysm rupture, mural complications of an
ascending aortic aneurysm, or subacute bacterial endocar-
ditis.8,9
Aortic aneurysms in Marfan syndrome can be broad
andmultiple because of the congenital fragility of the aortic
wall, which is known as cystic medial necrosis (CMN).10,11
In addition, the aneurysms are usually the dissecting type
and are often located in the thoracic region because the
ascending aorta is subjected to continuous pressure
changes.12 Therefore, true rather than dissecting abdomi-
nal aortic aneurysms (AAA) are so rare in patients with
Marfan syndrome8,13-15 that their precise characteristics
and long-term outcome are still unknown. We reviewed
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1162our experience of true AAA in six patients with Marfan
syndrome to reveal the details of each AAA and long-term
follow-up results after each repair.
PATIENTS AND METHODS
We investigated the clinical findings of six patients (3
men and 3 women) with Marfan syndrome, with a true
AAA, who underwent surgical treatment from 1972 to
2004. Every patient was diagnosed with Marfan syndrome
at the first presentation of the AAA according to published
guidelines,16,17 basically according to the family history
and physical examinations. No genetic examinations were
performed. The patients were a median age of 45 years
(range, 23-73 years) at the time of operation.
To investigate the clinical findings, we analyzed the
profiles of patients during the perioperative period of AAA
repair and long-term postoperative outcome, including
survival, formation of anastomotic false aneurysms, and
other Marfan-related cardiovascular complications such as
aortic regurgitation (AR), annuloaortic ectasia (AAE), and
aortic dissection. We performed histologic examination of
each specimen obtained at operation.
Each patient had been monitored regularly in the out-
patient clinic. Routine surveillance had been performed
with echography, angiography, or computed tomography
(CT) every 6 to 12 months since the late 1980s.
RESULTS
The profiles of patients at the time of operation for
AAA are summarized in Table I. Five of the six patients had
a family history of Marfan syndrome. Two patients had
symptoms or signs in the cardiovascular system, three in the
musculoskeletal system, and one in ocular system. The
median maximum diameter of AAA was 76 mm (range,
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emergency operation. One died during the operation due
to excessive bleeding. The other patient had undergone
two previous stent graft insertions at another hospital at 39
months and 28 months before the rupture; in this patient,
a tear from the stent graft caused the rupture.
Five patients who survived surgery were monitored for
a median duration of 27 months (range, 3-1493 months)
to investigate long-term results after AAA repair (Table II).
Cardiovascular complications that emerged during the
follow-up period consisted of AR, AAE, aortic dissection,
and anastomotic aneurysm. Four patients (80%) had AR,
two of which were diagnosed simultaneously at AAA repair.
Three patients (60%) had AAE, two of which were diag-
nosed simultaneously at AAA repair. One patient with both
AR and AAE underwent surgical repair of these problems
during the surgical procedure for aortic dissection of
DeBakey type I. The other patients with AR or AAE were
conservatively treated with observation.
Three (60%) patients had aortic dissection. One had
DeBakey IIIb type aortic dissection that occurred 56
months after the initial AAA repair, and graft replacement
was performed. Another had DeBakey IIIa type aortic
Table I. Profiles of patients at operation for abdominal ao
Patient
Year of
operation Age Sex Family history
1 1972 29 F Daughter
2 1974 23 M Mother, sibling, son, daughter
3 1982 39 F Daughter
4 1983 53 F None
5b 2003 51 M Son
6 2004 73 M Son
aEvery patient was diagnosed as having Marfan syndrome at the first presen
bThis patient had undergone endovascular aneurysm repair twice, at anothe
Table II. Long-term results after abdominal aortic aneury
Patient
Complication (post-op month when
AR AAE Aortic dissectionb
1 No No IIIb (56)
3 Yes (276) No No
4 Yes (0) Yes (0) IIIa (0)
5 Yes (8) Yes (8) I (8)
6 Yes (0) Yes (0) No
AR, Aortic regurgitation; AAE, annuloaortic ectasia.
aThe (0) means that the complication and the abdominal aortic aneurysm w
bAortic dissection is classified according to DeBakey’s classification.
cThe anastomotic false aneurysm was diagnosed at the same time as aortic d
dThe patient died from excessive bleeding during the operation for aortic d
eThe patient died suddenly 3 months after the operation. The cause of deatdissection that was repaired simultaneously with the AAA.The other patient had DeBakey type I aortic dissection that
occurred 8 months after AAA repair, and an emergency
Bentall operation and total arch replacement were per-
formed. An anastomotic aneurysm developed in one pa-
tient (20%) at 56 months after the initial AAA repair. This
was repaired simultaneously with surgical repair for
DeBakey IIIb type aortic dissection.
Two deaths occurred during the follow-up period (Ta-
ble II). The respective causes of death were perioperative
bleeding relating to aortic dissection, and sudden death of
unknown cause even after autopsy, 3 months after the
operation. The overall postoperative mortality of 40% was
remarkably high compared with that of non-Marfan pa-
tients with atherosclerotic AAAs, which was estimated to be
8% as surveyed from 422 patients treated between 1995
and 2005 in our department.
The clinicopathologic features of the aneurysmal wall
(Table III) included mural thrombus in only two patients
(33%), both of which were ruptured AAAs. Similarly, pre-
operative CT images typically demonstrated no mural
thrombus in the AAA (Fig). Mural calcification was also
observed in only two patients (33%), both of whom were
older (51 and 73 years old). The histologic examination,
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Niinami et al18 reported surgical procedures performed
for 101 patients withMarfan syndrome.Only three patients
(3%) had the initial surgical repair for aortic lesions involv-
ing the abdominal aorta, whereas 35 (35%) had aortic
reconstruction involving the thoracic aorta. This result
implies that it is relatively rare for patients with Marfan
syndrome to have the initial aortic lesion in the abdominal
aorta.18 In our current study, we described the precise
characteristics and long-term outcome after surgical treat-
ment for patients with Marfan syndrome, who had not a
dissecting but a true AAA as the initial aortic lesion.
Our results indicated that AAA occurred in relatively
young patients with Marfan syndrome. According to
Hertzer et al,19 the mean age of patients who underwent
AAA repair was 70 years, whereas it was 44.7 years in our
series of patients withMarfan syndrome undergoing similar
repairs. This seems to be the reason why our patients were
not diagnosed until their AAA became symptomatic or very
large. In addition, it seems that the AAA in a certain
percentage of patients with Marfan syndrome tends to
rupture, even if small. In our study, an AAAwith a diameter
of only 30 mm ruptured, resulting in death. The incidence
Table III. Clinicopathologic features of aneurysmal wall
Patient Mural thrombus Mural calcification CMN
1 No No Yes
2 Yes No Yes
3 No No Yes
4 No No Yes
5 Yes Yes Yes
6 No Yes Yes
CMN, Cystic medial necrosis.
Fig. This computed tomographic image shows an abdominal
aortic aneurysm in a patient with Marfan syndrome. There is no
obvious mural thrombus.of ruptured AAA in our series was also high, at 33%,whereas Hertzer et al reported a 6.5% incidence.19 Rupture
is therefore a serious threat for Marfan patients with AAA
because of the high mortality rate (50% in our study), and
considering these facts, immediate operation might be
indicated.20 Also high in our study was the incidence of
aortic dissection, which was 50%, and mortality, which was
67%.
The reason why such a small aneurysm in a relatively
young patient had ruptured or dissected might be the
fragility of the aortic wall, especially in the tunica media due
to CMN,which is one of common histologic findings in the
arterial wall affected byMarfan syndrome.10,11 Once CMN
occurs in the aorta, it becomes very susceptible to shear
stress from the blood stream, potentially resulting in early
dissection or rupture. Indeed, CMN was observed in every
aneurysmal wall in our series.
Another reason for the high postoperative mortality in
our series compared with that of non-Marfan AAAs might
be the high incidence of heart failure. A past reported series
revealed that aortic dissection and heart failure resulting
from severe aortic regurgitation are the main causes of
death in patients with Marfan syndrome,8 indicating that a
true AAAmight be one of the initial manifestations of serial
cardiovascular complications emerging in these patients.
One patient with rupture underwent stent graft inser-
tion before open surgery. Despite the recent vast expansion
of endovascular aneurysmal repair (EVAR) for atheroscle-
rotic AAA, there is no established consensus on endovas-
cular repair for Marfan-related AAA. In a study by Ince et
al,21 among six patients with Marfan syndrome who had
been treated with EVAR for dissection in the descending
thoracic aorta, elective conversion to surgical repair was
necessary in two patients (33%) at 22 and 43 months after
the initial EVAR. Considering the present status, conven-
tional graft replacement still seems to be the gold standard
to treat true AAA in Marfan syndrome.
AAAs in Marfan syndrome have less mural thrombus
than non-Marfan AAAs, which is a useful feature for diag-
nostic imaging. According toHa et al,22 an AAA in patients
with Marfan syndrome appears as a cystic or fusiform
dilatation of the aorta on chest or abdominal CT scans.
Compared with atherosclerotic aneurysms, the AAAs seen
inMarfan syndrome also rarely show intimal calcification or
atherosclerotic thrombosis, and they occur commonly and
develop more rapidly in younger patients.22 Indeed in our
study, none of the nonruptured AAAs had significant mural
thrombus. Therefore, when an AAA without mural throm-
bus is seen in a relatively young patient, underlying Marfan
syndrome should be suspected, even if the condition has
not yet been diagnosed. In addition, regular aortic imaging
with echocardiography and other imaging methods after
repair allows elective repair of aortic problems common to
patients withMarfan syndrome, because some authors have
reported that surgical treatment is associated with a high
risk of repeat dissection and recurrent aneurysm.23 These
efforts have prolonged the life expectancy of patients with
Marfan syndrome.8,23-26
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Our small case series revealed several specific features of
Marfan syndrome patients who had a true AAA as the first
significant disorder, such as the tendency to occur in rela-
tively young patients, lack of mural thrombus, susceptibility
to dissection and rupture, and poor life expectancy. Be-
cause our study design was limited due to its small number
of patients and long inclusion period (33 years), these
features will certainly need to be clarified more in accor-
dance with the future accumulation of information about
this rare condition. Finally, careful follow-up to detect for
possible cardiovascular complications, especially aortic dis-
section, is important for patients with a true AAA inMarfan
syndrome.
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